Theravance Biopharma Inc TBPH
17.03 USD 0.00 (+0.00%)
At closeSep 23, 2026, 4:00 PM EDT
17.63 +0.60 +3.52%
After hours · Sep 23, 4:00 PM ET
17.02 Day range 17.07
7.44 52-week range 11.71
- YTD
- -8.98%
- 1 year
- +58.71%
News
defenseworld.net Financial Analysis: Chugai Pharmaceutical (OTCMKTS:CHGCY) & Theravance Biopharma (NASDAQ:TBPH) Chugai Pharmaceutical (OTCMKTS:CHGCY - Get Free Report) and Theravance Biopharma (NASDAQ: TBPH - Get Free Report) are both healthcare companies, but which is the superior stock? We will contrast the…
defenseworld.net CASI Pharmaceuticals (NASDAQ:CASI) & Theravance Biopharma (NASDAQ:TBPH) Financial Analysis CASI Pharmaceuticals (NASDAQ: CASI - Get Free Report) and Theravance Biopharma (NASDAQ: TBPH - Get Free Report) are both small-cap healthcare companies, but which is the superior stock? We will…
marketbeat.com Zymeworks Completes Theravance Deal, Adds YUPELRI Cash Flow and Raises 2026 Outlook Zymeworks NASDAQ: ZYME said it has completed its acquisition of Theravance Biopharma, adding the COPD medicine YUPELRI, an acquired research portfolio, collaboration and royalty economics, Irish tax…
defenseworld.net Theravance Biopharma (NASDAQ:TBPH) versus vTv Therapeutics (NASDAQ:VTVT) Head-To-Head Contrast vTv Therapeutics (NASDAQ: VTVT - Get Free Report) and Theravance Biopharma (NASDAQ: TBPH - Get Free Report) are both small-cap healthcare companies, but which is the superior stock? We will compare…
defenseworld.net Theravance Biopharma (NASDAQ:TBPH) Sees Unusually-High Trading Volume – What’s Next? Shares of Theravance Biopharma, Inc. (NASDAQ: TBPH - Get Free Report) saw strong trading volume on Tuesday. 769,058 shares were traded during mid-day trading, an increase of 39% from the previous…
defenseworld.net Insider Selling: Theravance Biopharma (NASDAQ:TBPH) SVP Sells $226,737.42 in Stock Theravance Biopharma, Inc. (NASDAQ: TBPH - Get Free Report) SVP Rhonda Farnum sold 13,314 shares of the stock in a transaction dated Tuesday, September 15th. The stock was sold at an average price of…
zacks.com Theravance Bio (TBPH) Up 0.8% Since Last Earnings Report: Can It Continue? Theravance Bio (TBPH) reported earnings 30 days ago. What's next for the stock?
defenseworld.net Theravance Biopharma (NASDAQ:TBPH) Stock Price Crosses Above Fifty Day Moving Average – Time to Sell? Theravance Biopharma, Inc. (NASDAQ: TBPH - Get Free Report)'s share price crossed above its 50-day moving average during trading on Tuesday. The stock has a 50-day moving average of $16.95 and traded…
defenseworld.net Empowered Funds LLC Purchases Shares of 55,463 Theravance Biopharma, Inc. $TBPH Empowered Funds LLC acquired a new position in Theravance Biopharma, Inc. (NASDAQ: TBPH) during the undefined quarter, according to the company in its most recent filing with the Securities and…
gurufocus.com TBPH Stock Alert: Halper Sadeh LLC is Investigating Whether Theravance Biopharma, Inc. is Obtaining a Fair Price for its Shareholders Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Theravance Biopharma, Inc. (NASDAQ: TBPH) to Zymeworks Inc. for $17.00 per share.Hal
businesswire.com TBPH Stock Alert: Halper Sadeh LLC is Investigating Whether Theravance Biopharma, Inc. is Obtaining a Fair Price for its Shareholders NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Theravance Biopharma, Inc. (NASDAQ: TBPH) to Zymeworks Inc. for $17.00 per share. Halper Sadeh…
zacks.com TBPH Meets Q2 Earnings Estimates, to be Acquired by Zymeworks Theravance's Q2 earnings match estimates. Cost cuts and a $929 million Zymeworks deal follow ampreloxetine's discontinuation.
prnewswire.com Theravance Biopharma, Inc. Reports Second Quarter 2026 Financial Results and Provides Corporate Update Previously announced acquisition by Zymeworks expected to close in second half of 2026 YUPELRI ® Collaboration Revenue increased 11% year-over-year 1, from $18.7 million to $20.7 million, driven by…
defenseworld.net Theravance Biopharma, Inc. $TBPH Shares Acquired by Dimensional Fund Advisors LP Dimensional Fund Advisors LP boosted its holdings in Theravance Biopharma, Inc. (NASDAQ: TBPH) by 14.5% in the undefined quarter, according to the company in its most recent 13F filing with the…
gurufocus.com $HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--TBPH, IRDM, LCII, and PATK $HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--TBPH, IRDM, LCII, and PATK PR Newswire
seekingalpha.com Here's Why Zymeworks Inc. Paid $929M For Theravance Biopharma Zymeworks Inc. acquires Theravance Biopharma for $929M, pivoting to a hybrid biotech and royalty/cash-flow platform anchored by Yupelri. ZYME gains durable, growing cash flows—$60M annually from…
zacks.com Theravance Stock Down 3% After Zymeworks Announces Buyout TBPH falls after agreeing to a $929 million all-cash acquisition by Zymeworks, following a strategic review triggered by its failed ampreloxetine program.
gurufocus.com Are IRDM, TBPH, SYNA, TECH Obtaining Fair Deals for their Shareholders? Are IRDM, TBPH, SYNA, TECH Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, June 29, 2026
gurufocus.com $HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Theravance Biopharma, Inc. (NASDAQ: TBPH) $HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Theravance Biopharma, Inc. (NASDAQ: TBPH) PR Newswir
prnewswire.com Are IRDM, TBPH, SYNA, TECH Obtaining Fair Deals for their Shareholders? /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws
benzinga.com Zymeworks Targets Long-Term Cash Generation Through Theravance Acquisition Zymeworks will acquire Theravance Biopharma for $929 million, adding YUPELRI cash flows and expanding its portfolio.
benzinga.com Theravance Biopharma Discloses Termination Fee Of $32.5M After Acquisition Offer By Zymeworks The Merger Agreement contains certain customary termination rights for the Company and Parent. Subject to the terms and conditions of the Merger Agreement, the Company or Parent may terminate the…- benzinga.com Zymeworks To Acquire Theravance Biopharma At $17 Per Share For Total Cash Consideration Of $929M Acquisition adds YUPELRI® (revefenacin), the first and only approved nebulized long-acting muscarinic antagonist (LAMA) for the maintenance treatment of COPD to Zymeworks' portfolioAcquisition of…
benzinga.com This Vulcan Materials Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday Top Wall Street analysts changed outlook on top names. Check all changes on analyst ratings page. See what analysts think of VMC stock.
benzinga.com Semtech To Rally Around 28%? Here Are 10 Top Analyst Forecasts For Wednesday Wall Street analysts changed outlook on top names. For full view of changes, including upgrades/downgrades, see analyst ratings page.
benzinga.com Crude Oil Surges Over 6%; Target Profit Tops Views US stocks down amid Iran-US conflict. Tehran closed Strait of Hormuz & warned of firing on vessels. Dow down 2.45%, NASDAQ down 2.62%, S&P 500 down 2.34%.
benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session 
benzinga.com Dow Dips 900 Points; Best Buy Posts Upbeat Earnings U.S. stocks traded lower this morning, with the Dow Jones index falling more than 900 points on Tuesday amid the ongoing Iran-U.S. conflict. Iranian state media reported that Tehran has closed the…
benzinga.com Jefferson Capital, Mobix Labs And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session 
benzinga.com Why Cyclerion Therapeutics Shares Are Trading Higher By 44%; Here Are 20 Stocks Moving Premarket 
benzinga.com mF International, Theravance Biopharma And Other Big Stocks Moving Lower In Monday's Pre-Market Session 
benzinga.com Why GH Research Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket 
benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session 
benzinga.com Earnings Scheduled For November 10, 2025 
benzinga.com PACCAR Posts Downbeat Earnings, Joins Neuphoria Therapeutics, Citius Pharmaceuticals And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session 
benzinga.com Why Crown Holdings Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket 
benzinga.com Earnings Scheduled For August 12, 2025 
benzinga.com Earnings Scheduled For May 8, 2025 
benzinga.com Earnings Scheduled For February 26, 2025 
benzinga.com Earnings Scheduled For November 12, 2024 - benzinga.com Mama's Creations, GameStop And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
benzinga.com Earnings Scheduled For February 26, 2024 Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is projected to report quarterly earnings at $0.23 per share on revenue of $477.73 million.- benzinga.com Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session Shares of Applied Therapeutics, Inc.
- benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session
- benzinga.com Franklin Covey Shares Fall After Q1 Results, Joins Theravance Biopharma, Voyager Therapeutics And Other Big Stocks Moving Lower In Friday's Pre-Market Session U.S. stock futures were lower this morning, with the Dow Jones futures falling around 50 points on Friday.
- benzinga.com Roblox, Under Armour, GoPro, Nuvei And Other Big Stocks Moving Higher On Wednesday U.S. stocks traded mostly lower, with the Nasdaq Composite falling around 20 points on Wednesday. Here are some big stocks recording gains in today’s session.
- benzinga.com Earnings Scheduled For November 7, 2023 Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings for its third quarter.
- benzinga.com Stocks That Hit 52-Week Lows On Friday Friday's session saw 112 companies set new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Thursday During Thursday's session, 406 companies made new 52-week lows.
benzinga.com Stocks That Hit 52-Week Lows On Friday Friday's session saw 169 companies set new 52-week lows.